Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)

SHE:000952 Revenue

Hubei Guangji Pharmaceutical had revenue of 148.86M CNY in the quarter ending June 30, 2026, with 9.56% growth. This brings the company's total for the last twelve months to 651.57M, up 3.97% year-over-year. In the year 2025, Hubei Guangji Pharmaceutical had annual revenue of 623.97M, down -2.32%. That makes Hubei Guangji Pharmaceutical the 22,835th largest company in the world by revenue and 4,163rd in China.

• Revenue (ttm): 651.57M
• Revenue Growth: +3.97%
• P/S Ratio: 3.11
• Revenue / Employee: 559.77K
• Employees: 1,164
• Market Cap: 2.03B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• domestic 404.97M 64.9%
• Foreign 219.00M 35.1%

Fiscal year ended Dec 31, 2025 See the full SHE:000952 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	623.97M	-14.83M	-2.32%
Dec 31, 2024	638.80M	-99.02M	-13.42%
Dec 31, 2023	737.82M	-59.82M	-7.50%
Jan 1, 2023	797.64M	12.07M	1.54%
Jan 1, 2022	785.57M	97.40M	14.15%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error